<DOC>
	<DOC>NCT01777620</DOC>
	<brief_summary>This is a safety and efficacy study of BOTOX® in subjects with facial rhytides (glabellar lines and crow's feet lines).</brief_summary>
	<brief_title>A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Glabellar lines and crow's feet lines No prior use of botulinum toxin therapy of any serotype for any reason Previous facial cosmetic surgery, tissue grafting, or tissue augmentation with silicone or fat or other permanent fillers Planning a facial cosmetic procedure during the study period Diagnosis of myasthenia gravis, EatonLambert Syndrome, and/or amyotrophic lateral sclerosis Anticipated need for treatment with botulinum toxin of any serotype for any reason during the study (other than study treatment)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>